Belief BioMed ("BBM") today announced that BBM-H901 (generic name: Dalnacogene Ponparvovec Injection), has been officially approved by the Pharmaceutical Administration Bureau of Macao Special ...
Belief BioMed ("BBM") and Grand Life Sciences Group Co., Ltd. ("Grand Life Sciences") today announced an exclusive collaboration agreement. Under the agreement, Belief BioMed will grant Grand Life ...
News-Medical.Net on MSN
Preventing postoperative rebleeding in intracerebral hemorrhage surgery
Background Intracerebral hemorrhage (ICH) is the stroke subtype with the highest mortality and disability rates, and early ...
Dublin, March 10, 2026 (GLOBE NEWSWIRE) -- The "Corifact Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. The ...
You will be redirected to our submission process. Perioperative coagulation management is central to cardiovascular surgery patients, shaping outcomes in this highly vulnerable patient cohort.
The coagulation system is composed of cells, proteins and processes that mediate blood clotting. Damage to a blood vessel wall triggers the system, initiating interactions between platelets and blood ...
Context: Factor V deficiency is a rare abnormality of coagulation as para-haemopilia, originally described by Owren in 1947, ...
Vietnam Investment Review on MSN
Belief BioMed gains Macao approval for hemophilia B gene therapy
SHANGHAI, March 19, 2026 /PRNewswire/ -- Belief BioMed ("BBM") today announced that BBM-H901 (generic name: Dalnacogene Ponparvovec Injection), has been officially approved by the Pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results